Search results

‘We are all born into a particular tribal culture. Beginning life as part of a tribe, we become connected to our tribal consciousness and collective willpower by absorbing its strengths and weaknesses, beliefs, superstitions and fears. Through our interactions with family and other groups, we learn the power of sharing with other people. We learn how painful it can be to be excluded from a group and its energy. We also learn the power of sharing a moral and ethical code handed down from generation to generation.’ (Myss, 1997)We are all aware that, since time immemorial, there has been world‐wide stigma and discrimination against those unfortunate enough to suffer from mental ill health. Governments, as well as their electorates, have stigmatised and discriminated against those who suffer most.Many of those who have been entrusted with the care and support of mentally ill people have all too often taken a discriminatory line in their approach, which has not aided patients' recovery. Clergy of all faiths and beliefs have very often been at the forefront, receiving calls for help from families in despair, unable to cope with a son, daughter, husband or wife suffering from a mental illness. Yet they are often ill‐equipped and untrained in how to respond appropriately.

This chapter uses Goffman’s concept of total institutions in a comparative case study approach to explore the role of psychotropic drugs in the process of transinstitutionalization.

This chapter interprets psychotropic drug use across four institutionalized contexts in the United States: the active-duty U.S. military, nursing homes and long-term care facilities, state and federal prisons, and the child welfare system.

This chapter documents a major unintended consequence of transinstitutionalization – the questionable distribution of psychotropics among vulnerable populations. The patterns of psychotropic use we synthesize suggest that total institutions are engaging in ethically and medically questionable practices and that psychotropics are being used to serve the bureaucratic imperatives for social control in the era of transinstitutionalization.

Psychotropic prescribing practices require close surveillance and increased scrutiny in institutional settings in the United States. The flows of mentally ill people through a vast network of total institutions raises questions about the wisdom and unintended consequences of psychotropic distribution to vulnerable populations, despite health policy makers’ efforts regulating their distribution. Medical sociologists must examine trans-institutional power arrangements that converge around the mental health of vulnerable groups.

This is the first synthesis and interpretive review of psychotropic use patterns across institutional systems in the United States. This chapter will be of value to medical sociologists, mental health professionals and administrators, pharmacologists, health system pharmacists, and sociological theorists.

Since the tragic events of 9/11, faith has become an important discourse in society as a whole. This article explores aspects of that discourse in our multicultural society with special reference to mental health and well‐being, and describes a conference set up by NIMHE/Staffordshire University and the National Forum on Spirituality and Mental Health to explore how belief systems can affect people's well‐being and their recovery from mental illness.

Western societies have been shaken by the economic crisis brought on by ‘casino capitalism’ and the recklessness of the financial institutions. Once esteemed financial institutions, like Lehman Brothers, are now shown to have used dubious accounting methods to cover losses; and accountants, regulators and governments have come under scrutiny. In public life, the scandal of MPs' expenses at Westminster and the blockages in legislative assemblies in the US are compounded in England by reports of deficient and degrading care in acute hospitals, where organisational considerations appear to have taken over from the prime mission of patient care. At this time, a new, or perhaps rediscovered, form of leadership is required. One that taps into the spirit, the animating and motivating force within individuals and groups, and uses values to create a better public service for all.

This index covers all issues between February 2005 (Volume 9, Issue 1) and November 2008 (Volume 12, Issue 4). Numbers in bold refer to yolume, numbers in brackets refer to issue, with subsequent numbers to pages.

This paper aims to describe the content and import of a conference held in partnership between Staffordshire University and The National Spirituality and Mental Health Forum on the importance of considering life in the context of human mortality, and the meaning and purpose of our lives. It was one of a series of conferences on the theme of health and multi‐belief systems; other conferences were on mental health and civic regeneration. A fourth conference is planned for 2012 on dementia and beliefs.

The conference and its format, including case studies is placed within the intense debate concerning the meaning of life in the context of death and what might be beyond “the grave”. With this conversation, and the issue of assisted dying becoming more prevalent, it was felt important to bring into the paper not just philosophical writings but examples from novels and “popular culture” which highlight the intensity of the dialogue.

Considering the perspectives of a variety of major belief systems assists in relating to and caring for the increasing diversity of older people and their carers when the ultimate challenge of dying is being faced.

As the discourse around assisted dying, belief systems and dignity come more to the fore, staff in health and social care will need time to discuss what are crucial issues for those they serve.

As religion and other belief systems come back into focus, partly through equalities legislation and increased demographic diversity, the Staffordshire University/National Spirituality and Mental Health Forum conference series has been an innovative way of meeting this renewed need.

This case examines the public controversy that erupted over the increasingly high price of EpiPens. Mylan Inc. (Mylan), a generic drug maker, bought the EpiPen product line from Merck in 2007. Since that time, the company both invested in marketing to raise awareness for the drug and dramatically increased the price, lifting it from $100 to $600 per two pack in the U.S. In 2016, simmering consumer anger about the high prices of pharmaceutical drugs finally reached a boiling point and a media firestorm ensued. The case challenges students to think about the role of fairness in pricing. How can Mylan justify the dramatic price increases? How can it justify the variation in prices across countries, as an EpiPen is priced at an equivalent of $85 in France? The case challenges students to think about how they would handle a public controversy. The EpiPen case is well suited for students in MBA, MBA for Executives, and executive education programs. For MBA students, it can be placed in first-year marketing, pricing, or marketing communications courses. For executives, it can serve as a vehicle to discuss both ethical issues of pricing and how to handle a public controversy.